Cassava Sciences Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Consumer Staples Select Sector SPDR Fund trades at $84.53. The key difference: Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | XLP | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | — |
52-Week High | $4.64 | $90.00 |
52-Week Low | $0.87 | $75.61 |
Enterprise Value | -$34.93M | — |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →